Mesoblast Limited
$13.28
-0.67 (-4.80%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -10.7%
- 3 Months
- -20.1%
- YTD
- -26.4%
- 1 Year
- -26.0%
- 3 Year annualized
- +74.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 53.9%
- Largest decline max drawdown, since Oct 2021
- -87.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.29
Own MESO?
See how MESO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.